This collaboration marks Everest’s strategic expansion into ophthalmology, a high-potential “blue-ocean” therapeutic area...
The strategic partnership is set to fully unlock the patent value and productisation capabilities of CoolMPS, complementing MGI's tried-and-true StandardMPS technology ...
China has designated weight management as a national health priority, integrating it into the Healthy China 2030 strategy through a series of government-led initiatives...
EVM14, an off-the-shelf therapeutic mRNA cancer vaccine, was developed based on Everest Medicines' proprietary mRNA platform...
The Smartee Sleep Aligners Series addresses this challenge through digitally customised clear aligners with a dual-splint locking system that advances the mandible while distributing occlusal forces to stabilise the jaw...
The 17,000-woman study, led by Peking University Shenzhen Hospital, sets three world records and integrates PHASiFY™ DNA concentration technology with AI-powered diagnostics to advance scalable, non-invasive screening in line with WHO’s 2030 elimination goals....
The study applies PHASE Scientific’s proprietary PHASiFY urine-based DNA concentration technology...
Yang Huang, Head of China Healthcare Research at J.P. Morgan, unpacks how favourable policies, demographic shifts, and global collaborations are shaping the future of biopharma and medtech investment in China. ...
XS LLM integrates multimodal capabilities, image and speech recognition, natural language processing, large-scale medical knowledge storage, and reasoning ...
The study will examine the influence of human-AI collaboration models on consumer adoption...
